Related Experiment Video
Updated: May 14, 2025

Collecting Saliva and Measuring Salivary Cortisol and Alpha-amylase in Frail Community Residing Older Adults via Family Caregivers
Published on: December 18, 2013
Serum and Saliva Biomolecules in Periodontitis Patients with and without Alzheimer's Disease
D Öztürk1, I Midi2, M Alaylıoğlu3
1Department of Periodontology, Faculty of Dentistry, Marmara University, Istanbul, Türkiye.
Background:
Alzheimer's disease (AD) and periodontitis are linked to a systemic pro-inflammatory state, potentially influencing the progression of one another.
Aims:
This study aims to evaluate serum and salivary IL-10, IL-18, and resistin levels between periodontitis patients with and without AD.
Materials And Methods:
Forty-three periodontitis patients with AD (mild or moderate), 40 without AD were included in the study. To determine the cognitive status Mini-Mental State-Examination (MMSE) test was used. Samples of blood and saliva were collected a day after measurement of periodontal parameters. ELISA method was used to analyze IL-10, IL-18, and resistin levels both in serum and saliva samples.
Results:
No difference was detected regarding clinical periodontal parameters across both groups (P > 0.05). The periodontitis patients with AD had elevated serum IL-18 levels compared to those without AD (P < 0.05). In the AD group, salivary resistin levels were higher in severe periodontitis patients than in moderate ones (P < 0.01). Furthermore, MMSE score was correlated negatively with serum levels of IL-18 (P < 0.05), and salivary levels of resistin positively with gingival index, bleeding on probing, and probing depth (P < 0.05).
Conclusion:
This study confirms the possible role of serum IL-18 in the inflammatory process of AD. Additionally, the present relationship between salivary resistin levels and the severity of periodontitis in AD patients needs further investigation to fully understand the implications.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment

